Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 2024-03-04 12:11 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Harald Gurvin | – | acquisition | 16,57 | 16,55 NOK | 2024-03-04 | NO0010714785 | XOSL - Oslo Stock Exchange | rules · til gjennomgang |
Vedlegg
- Attachment 240304.pdf (tekst hentet ut)
Meldingstekst
Oslo, Norway, March 4, 2024 - Primary insider Harald Gurvin, Chief Financial Officer of Nykode Therapeutics ASA, has today acquired 20,000 shares in Nykode Therapeutics ASA at an average price of NOK 16.59 per share.
Please see further details in the attached document.